Search

Your search keyword '"Fidler-Benaoudia, Miranda M."' showing total 29 results
Start Over Author "Fidler-Benaoudia, Miranda M."
29 results on '"Fidler-Benaoudia, Miranda M."'

2. Physical activity and physical fitness assessments in adolescents and young adults diagnosed with cancer: a scoping review

Author

Caru, Maxime, Wurz, Amanda, Brunet, Jennifer, Barb, Emily D., Adams, Scott C., Roth, Michael E., Winters-Stone, Kerri, Fidler-Benaoudia, Miranda M., Dandekar, Smita, Ness, Kirsten K., Culos-Reed, S. Nicole, Schulte, Fiona, Rao, Pooja, Mizrahi, David, Swartz, Maria Chang, Smith, Marlie, Valle, Carmina G., Kadan-Lottick, Nina S., Dieli-Conwright, Christina M., and Schmitz, Kathryn H.

Published
2023
Full Text
View/download PDF

6. Alberta Childhood Cancer Survivorship Research Program

Author

Harper, Andrew, primary, Schulte, Fiona, additional, Guilcher, Gregory M. T., additional, Truong, Tony H., additional, Reynolds, Kathleen, additional, Spavor, Maria, additional, Logie, Natalie, additional, Lee, Joon, additional, and Fidler-Benaoudia, Miranda M., additional

Published
2023
Full Text
View/download PDF

7. Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study

Author

Reulen, Raoul C., primary, Winter, David L., additional, Diallo, Ibrahim, additional, Veres, Cristina, additional, Llanas, Damien, additional, Allodji, Rodrigue S., additional, Bagnasco, Francesca, additional, Bárdi, Edit, additional, Feijen, Elizabeth A.M., additional, Alessi, Daniela, additional, Fidler-Benaoudia, Miranda M., additional, Høgsholt, Stine, additional, Teepen, Jop C., additional, Linge, Helena, additional, Haddy, Nadia, additional, Byrne, Julianne, additional, Debiche, Ghazi, additional, Grabow, Desiree, additional, Gudmundsdottir, Thorgerdur, additional, Fauchery, Romain, additional, Zrafi, Wael, additional, Michel, Gisela, additional, Øfstaas, Hilde, additional, Kaatsch, Peter, additional, Vu-Bezin, Giao, additional, Jenkinson, Helen, additional, Kaiser, Melanie, additional, Skinner, Roderick, additional, Cole, Trevor, additional, Waespe, Nicolas, additional, Sommer, Grit, additional, Nordenfelt, Susanne, additional, Jankovic, Momcilo, additional, Lähteenmäki Taalas, Tuomas, additional, Maule, Milena M., additional, van der Pal, Helena J.H., additional, Ronckers, Cécile M., additional, van Leeuwen, Flora E., additional, Kok, Judith L., additional, Terenziani, Monica, additional, Winther Gunnes, Maria, additional, Wiebe, Thomas, additional, Sacerdote, Carlotta, additional, Jakab, Zsuzsanna, additional, Haupt, Riccardo, additional, Lähteenmäki, Päivi M., additional, Zadravec Zaletel, Lorna, additional, Kuehni, Claudia E., additional, Falck Winther, Jeanette, additional, Kremer, Leontien C.M., additional, Hjorth, Lars, additional, de Vathaire, Florent, additional, and Hawkins, Michael M., additional

Published
2023
Full Text
View/download PDF

13. Age disparities in stage-specific colon cancer survival across seven countries: an ICBP SURVMARK-2 population-based study

Author

Pilleron, Sophie, Charvat, Hadrien, Araghi, Marzieh, Arnold, Melina, Fidler-Benaoudia, Miranda M, Bardot, Aude, Guren, Marianne Grønlie, Tervonen, Hanna, Little, Alana, O'Connell, Dianne L, Gavin, Anna, De, Prithwish, Aagaard Thomsen, Linda, Møller, Bjørn, Jackson, Christopher, Bucher, Oliver, Walsh, Paul M, Vernon, Sally, Bray, Freddie, and Soerjomataram, Isabelle

Subjects
SDG 3 - Good Health and Well-being
Abstract

We sought to understand the role of stage at diagnosis in observed age disparities in colon cancer survival among people aged 50-99 using population-based cancer registry data from seven high-income countries: Australia, Canada, Denmark, Ireland, New Zealand, Norway and the United Kingdom. We used colon cancer incidence data for the period 2010-2014. We estimated the three-year net survival, as well as the three-year net survival conditional on surviving at least six months and one year after diagnosis, by country and stage at diagnosis (categorised as localised, regional or distant) using flexible parametric excess hazard regression models. In all countries, increasing age was associated with lower net survival. For example, three-year net survival (95% confidence interval) was 81% (80 to 82) for 50-64 year olds and 58% (56 to 60) for 85-99 year olds in Australia, and 74% (73 to 74) and 39% (39 to 40) in the United Kingdom, respectively. Those with distant stage colon cancer had the largest difference in colon cancer survival between the youngest and the oldest patients. Excess mortality for the oldest patients with localised or regional cancers was observed during the first six months after diagnosis. Older patients diagnosed with localised (and in some countries regional) stage colon cancer who survived six months after diagnosis experienced the same survival as their younger counterparts. Further studies examining other prognostic clinical factors such as comorbidities and treatment, and socioeconomic factors are warranted to gain further understanding of the age disparities in colon cancer survival. This article is protected by copyright. All rights reserved.

Published
2020

14. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study

Author

Reulen, Raoul C, primary, Wong, Kwok F, additional, Bright, Chloe J, additional, Winter, David L, additional, Alessi, Daniela, additional, Allodji, Rodrigue M, additional, Bagnasco, Francesca, additional, Bárdi, Edit, additional, Bautz, Andrea, additional, Byrne, Julianne, additional, Feijen, Elizabeth AM, additional, Fidler-Benaoudia, Miranda M, additional, Diallo, Ibrahim, additional, Garwicz, Stanislaw, additional, Grabow, Desiree, additional, Gudmundsdottir, Thorgerdur, additional, Guha, Joyeeta, additional, Haddy, Nadia, additional, Høgsholt, Stine, additional, Jankovic, Moncilo, additional, Kaatsch, Peter, additional, Kaiser, Melanie, additional, Kuonen, Rahel, additional, Linge, Helena, additional, Øfstaas, Hilde, additional, Ronckers, Cecile M, additional, Hau, Eva-Maria, additional, Skinner, Roderick, additional, van Leeuwen, Flora E, additional, Teepen, Jop C, additional, Veres, Cristina, additional, Zrafi, Wael, additional, Debiche, Ghazi, additional, Llanas, Damien, additional, Terenziani, Monica, additional, Vu-Bezin, Giao, additional, Wesenberg, Finn, additional, Wiebe, Thomas, additional, Sacerdote, Carlotta, additional, Jakab, Zsuzsanna, additional, Haupt, Riccardo, additional, Lähteenmäki, Päivi M, additional, Zadravec Zaletel, Lorna, additional, Kuehni, Claudia E, additional, Winther, Jeanette F, additional, de Vathaire, Florent, additional, Kremer, Leontien C, additional, Hjorth, Lars, additional, and Hawkins, Michael M, additional

Published
2020
Full Text
View/download PDF

15. Age disparities in stage‐specific colon cancer survival across seven countries: An International Cancer Benchmarking PartnershipSURVMARK‐2 population‐based study

Author

Pilleron, Sophie, primary, Charvat, Hadrien, additional, Araghi, Marzieh, additional, Arnold, Melina, additional, Fidler‐Benaoudia, Miranda M., additional, Bardot, Aude, additional, Guren, Marianne Grønlie, additional, Tervonen, Hanna, additional, Little, Alana, additional, O'Connell, Dianne L., additional, Gavin, Anna, additional, De, Prithwish, additional, Aagard Thomsen, Linda, additional, Møller, Bjørn, additional, Jackson, Christopher, additional, Bucher, Oliver, additional, Walsh, Paul M., additional, Vernon, Sally, additional, Bray, Freddie, additional, and Soerjomataram, Isabelle, additional

Published
2020
Full Text
View/download PDF

21. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study.

Author

Reulen, Raoul C., Wong, Kwok F., Bright, Chloe J., Winter, David L., Alessi, Daniela, Allodji, Rodrigue M., Bagnasco, Francesca, Bárdi, Edit, Bautz, Andrea, Byrne, Julianne, Feijen, Elizabeth A. M., Fidler-Benaoudia, Miranda M., Diallo, Ibrahim, Garwicz, Stanislaw, Grabow, Desiree, Gudmundsdottir, Thorgerdur, Guha, Joyeeta, Haddy, Nadia, Høgsholt, Stine, and Jankovic, Moncilo

Subjects
CHILDHOOD cancer, DISEASE risk factors, COMA, CANCER survivors, TESTICULAR cancer, GALLBLADDER cancer, MEDICAL sciences
Published
2021
Full Text
View/download PDF

22. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup

Author

Allodji, Rodrigue S., primary, Hawkins, Mike M., additional, Bright, Chloe J., additional, Fidler-Benaoudia, Miranda M., additional, Winter, David L., additional, Alessi, Daniela, additional, Fresneau, Brice, additional, Journy, Neige, additional, Morsellino, Vera, additional, Bárdi, Edit, additional, Bautz, Andrea, additional, Byrne, Julianne, additional, Feijen, Elizabeth (Lieke) AM., additional, Teepen, Jop C., additional, Vu-Bezin, Giao, additional, Rubino, Carole, additional, Garwicz, Stanislaw, additional, Grabow, Desiree, additional, Gudmundsdottir, Thorgerdur, additional, Guha, Joyeeta, additional, Hau, Eva-Maria, additional, Jankovic, Momcilo, additional, Kaatsch, Peter, additional, Kaiser, Melanie, additional, Linge, Helena, additional, Muraca, Monica, additional, Llanas, Damien, additional, Veres, Cristina, additional, Øfstaas, Hilde, additional, Diallo, Ibrahima, additional, Mansouri, Imene, additional, Ronckers, Cecile M., additional, Skinner, Roderick, additional, Terenziani, Monica, additional, Wesenberg, Finn, additional, Wiebe, Thomas, additional, Sacerdote, Carlotta, additional, Jakab, Zsuzsanna, additional, Haupt, Riccardo, additional, Lähteenmäki, Päivi, additional, Zaletel, Lorna Zadravec, additional, Kuehni, Claudia E., additional, Winther, Jeanette F., additional, Michel, Gisela, additional, Kremer, Leontien C.M., additional, Hjorth, Lars, additional, Haddy, Nadia, additional, de Vathaire, Florent, additional, and Reulen, Raoul C., additional

Published
2019
Full Text
View/download PDF

24. A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom.

Author

Fidler-Benaoudia, Miranda M, Oeffinger, Kevin C, Yasui, Yutaka, Robison, Leslie L, Winter, David L, Reulen, Raoul C, Leisenring, Wendy M, Chen, Yan, Armstrong, Gregory T, and Hawkins, Michael M

Subjects
*CHILDHOOD cancer, *CANCER survivors, *RESPIRATORY diseases, *RESEARCH funding, *TUMORS, *LYMPHOMAS, *SARCOMA, CENTRAL nervous system tumors
Abstract

Background: It is unclear whether late-effect risks among childhood cancer survivors vary internationally. We compared late mortality in the North American Childhood Cancer Survivor Study (CCSS) and British Childhood Cancer Survivor Study (BCCSS).Methods: Late mortality was assessed among 49 822 5-year survivors of childhood cancer diagnosed before 15 years of age from 1970 to 1999 (CCSS, n = 31 596; BCCSS, n = 18 226) using cumulative mortality probabilities (CM%) and adjusted ratios of the standardized mortality ratio.Results: The all-cause CM% at 10 years from diagnosis was statistically significantly lower in the CCSS (4.7%, 95% confidence interval [CI] = 4.5% to 5.0%) compared with the BCCSS (6.9%, 95% CI = 6.5% to 7.2%), attributable to a lower probability of death from recurrence or progression of the primary cancer, with statistically significant differences observed in survivors of leukemia, lymphoma, central nervous system tumors, and sarcoma. However, at 40 years from diagnosis, the CCSS had a greater CM% (22.3% vs 19.3%), attributable to a twofold higher risk of mortality from subsequent malignant neoplasms, cardiac and respiratory diseases, and other health-related causes. Differences increased when assessed by follow-up interval, with the CCSS faring worse as time-since-diagnosis increased. Finally, the gap in all-cause mortality widened more recently, with CCSS survivors diagnosed in 1990-1999 experiencing one-half the excess deaths observed in the BCCSS (ratios of the standardized mortality ratio = 0.5, 95% CI = 0.5 to 0.6).Conclusions: Our findings suggest that US survivors may have received more intensive regimens to achieve sustainable remission and cure, but the cost of this approach was a higher risk of death from late effects. Although the clinical impact of these differences is unclear, our results provide important evidence to aid the discussion of late effects management. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

25. Age disparities in stage‐specific colon cancer survival across seven countries: An International Cancer Benchmarking PartnershipSURVMARK‐2 population‐based study.

Author

Pilleron, Sophie, Charvat, Hadrien, Araghi, Marzieh, Arnold, Melina, Fidler‐Benaoudia, Miranda M., Bardot, Aude, Grønlie Guren, Marianne, Tervonen, Hanna, Little, Alana, O'Connell, Dianne L., Gavin, Anna, De, Prithwish, Aagard Thomsen, Linda, Møller, Bjørn, Jackson, Christopher, Bucher, Oliver, Walsh, Paul M., Vernon, Sally, Bray, Freddie, and Soerjomataram, Isabelle

Subjects
COLON cancer, PROGNOSIS, OLDER patients, OLDER people, DIAGNOSIS
Abstract

We sought to understand the role of stage at diagnosis in observed age disparities in colon cancer survival among people aged 50 to 99 years using population‐based cancer registry data from seven high‐income countries: Australia, Canada, Denmark, Ireland, New Zealand, Norway and the United Kingdom. We used colon cancer incidence data for the period 2010 to 2014. We estimated the 3‐year net survival, as well as the 3‐year net survival conditional on surviving at least 6 months and 1 year after diagnosis, by country and stage at diagnosis (categorised as localised, regional or distant) using flexible parametric excess hazard regression models. In all countries, increasing age was associated with lower net survival. For example, 3‐year net survival (95% confidence interval) was 81% (80‐82) for 50 to 64 year olds and 58% (56‐60) for 85 to 99 year olds in Australia, and 74% (73‐74) and 39% (39‐40) in the United Kingdom, respectively. Those with distant stage colon cancer had the largest difference in colon cancer survival between the youngest and the oldest patients. Excess mortality for the oldest patients with localised or regional cancers was observed during the first 6 months after diagnosis. Older patients diagnosed with localised (and in some countries regional) stage colon cancer who survived 6 months after diagnosis experienced the same survival as their younger counterparts. Further studies examining other prognostic clinical factors such as comorbidities and treatment, and socioeconomic factors are warranted to gain further understanding of the age disparities in colon cancer survival. What's new? Survival rates for colon cancer have improved over the past few decades. However, survival rates can vary by as much as 35% between younger and older patients. In this study, the authors found that this "age gap" occurred primarily within the first year after diagnosis. Stage at diagnosis also had a greater impact for older patients. Early diagnosis and individualized management should thus help to reduce early mortality in older patients. Further studies on additional prognostic factors such as comorbidities, etc., are also warranted. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

26. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup

Author

Allodji, Rodrigue S, Hawkins, Mike M, Bright, Chloe J, Fidler-Benaoudia, Miranda M, Winter, David L, Alessi, Daniela, Fresneau, Brice, Journy, Neige, Morsellino, Vera, Bárdi, Edit, Bautz, Andrea, Byrne, Julianne, Feijen, Elizabeth Lieke Am, Teepen, Jop C, Vu-Bezin, Giao, Rubino, Carole, Garwicz, Stanislaw, Grabow, Desiree, Gudmundsdottir, Thorgerdur, Guha, Joyeeta, Hau, Eva-Maria, Jankovic, Momcilo, Kaatsch, Peter, Kaiser, Melanie, Linge, Helena, Muraca, Monica, Llanas, Damien, Veres, Cristina, Øfstaas, Hilde, Diallo, Ibrahima, Mansouri, Imene, Ronckers, Cecile M, Skinner, Roderick, Terenziani, Monica, Wesenberg, Finn, Wiebe, Thomas, Sacerdote, Carlotta, Jakab, Zsuzsanna, Haupt, Riccardo, Lähteenmäki, Päivi, Zaletel, Lorna Zadravec, Kuehni, Claudia E, Winther, Jeanette F, Michel, Gisela, Kremer, Leontien C M, Hjorth, Lars, Haddy, Nadia, De Vathaire, Florent, and Reulen, Raoul C

Subjects
610 Medicine & health, 360 Social problems & social services, 3. Good health
Abstract

BACKGROUND Survivors of childhood cancers are at risk of developing subsequent primary leukaemias (SPLs), but the long-term risks beyond 20 years of treatment are still unclear. We investigated the risk of SPLs in five-year childhood cancer survivors using a large-scale pan-European (PanCareSurFup) cohort and evaluated variations in the risk by cancer and demographic factors. METHODS This largest-ever assembled cohort comprises 69,460 five-year childhood cancer survivors from 12 European countries. Standardised incidence ratios (SIRs) and absolute excess risks (AERs) were calculated. RESULTS One hundred fifteen survivors developed an SPL including 86 myeloid leukaemias (subsequent primary myeloid leukaemias [SPMLs]), 17 lymphoid leukaemias and 12 other types of leukaemias; of these SPLs, 31 (27%) occurred beyond 20 years from the first childhood cancer diagnosis. Compared with the general population, childhood cancer survivors had a fourfold increased risk (SIR = 3.7, 95% confidence interval [CI]: 3.1 to 4.5) of developing leukaemia, and eight leukaemias per 100,000 person-years (AER = 7.5, 95% CI: 6.0 to 9.2) occurred in excess of that expected. The risks remained significantly elevated beyond 20 years from the first primary malignancy (SIR = 2.4, 95% CI: 1.6 to 3.4). Overall, the risk ratio for SPML (SIR = 5.8, 95% CI: 4.6 to 7.1) was higher than that for other SPLs. CONCLUSIONS We demonstrate that beyond 20 years after childhood cancer diagnosis, survivors experience an increased risk for SPLs compared with that expected from the general population. Our findings highlight the need for awareness by survivors and their healthcare providers for potential risk related to SPL.

27. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.

Author

Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Grønlie Guren M, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Aagard Thomsen L, Møller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, and Soerjomataram I

Subjects
Aged, Aged, 80 and over, Australia epidemiology, Canada epidemiology, Colonic Neoplasms diagnosis, Colorectal Neoplasms diagnosis, Denmark epidemiology, Female, Humans, Incidence, Ireland epidemiology, Male, Middle Aged, Neoplasm Staging, New Zealand epidemiology, Norway epidemiology, Registries, United Kingdom epidemiology, Benchmarking statistics & numerical data, Colonic Neoplasms mortality, Colorectal Neoplasms mortality
Abstract

We sought to understand the role of stage at diagnosis in observed age disparities in colon cancer survival among people aged 50 to 99 years using population-based cancer registry data from seven high-income countries: Australia, Canada, Denmark, Ireland, New Zealand, Norway and the United Kingdom. We used colon cancer incidence data for the period 2010 to 2014. We estimated the 3-year net survival, as well as the 3-year net survival conditional on surviving at least 6 months and 1 year after diagnosis, by country and stage at diagnosis (categorised as localised, regional or distant) using flexible parametric excess hazard regression models. In all countries, increasing age was associated with lower net survival. For example, 3-year net survival (95% confidence interval) was 81% (80-82) for 50 to 64 year olds and 58% (56-60) for 85 to 99 year olds in Australia, and 74% (73-74) and 39% (39-40) in the United Kingdom, respectively. Those with distant stage colon cancer had the largest difference in colon cancer survival between the youngest and the oldest patients. Excess mortality for the oldest patients with localised or regional cancers was observed during the first 6 months after diagnosis. Older patients diagnosed with localised (and in some countries regional) stage colon cancer who survived 6 months after diagnosis experienced the same survival as their younger counterparts. Further studies examining other prognostic clinical factors such as comorbidities and treatment, and socioeconomic factors are warranted to gain further understanding of the age disparities in colon cancer survival., (© 2020 Union for International Cancer Control.)

Published
2021
Full Text
View/download PDF

28. International Trends in the Incidence of Cancer Among Adolescents and Young Adults.

Author

Gupta S, Harper A, Ruan Y, Barr R, Frazier AL, Ferlay J, Steliarova-Foucher E, and Fidler-Benaoudia MM

Subjects
Adolescent, Adult, Age Factors, Female, Global Health, Humans, Incidence, Male, Young Adult, Neoplasms epidemiology
Abstract

Background: Although adolescent and young adult (AYA) cancers represent a unique spectrum of malignancies, epidemiological studies of cancer incidence often group AYAs together with younger or older populations, obscuring patterns specific to this population., Methods: We examined AYA cancer incidence trends in 41 countries over a 15-year period using the CI5plus database. Truncated age-standardized incidence rates were calculated and the annual percentage change was assessed, with statistical significance corresponding to a 95% confidence interval that does not include zero., Results: From 1998 to 2012, the 41 included countries contributed a total of 1 846 588 cancer cases and 3.1 billion person-years among AYAs. Although statistically significant increases in the overall cancer burden were observed in 23 countries, the magnitude varied considerably, with the greatest increase in incidence observed in South Korea (annual percentage change2002-2012 = 8.5%, 95% confidence interval = 7.6% to 9.4%) due to thyroid cancer. Notable trends included sharp increases in the incidence of obesity-related malignancies among AYAs; indeed, statistically significant increases were observed among AYAs for 10 of 11 and 9 of 11 obesity-related cancer sites in the US and UK, respectively, with at least five obesity-related cancers statistically significantly increasing in Canada, Japan, South Korea, Australia, and the Netherlands. Other striking trends were noted for thyroid and testicular cancer, with statistically significantly increasing rates observed in 33 and 22 countries, respectively, whereas statistically significant declines in incidence were observed for smoking-related cancers, cervical cancer, and Kaposi sarcoma in many countries., Conclusions: Our results highlight the future health-care needs related to treatment as well as the urgency for public health initiatives that can mitigate the increasing burden of cancer in AYAs., (© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results